Cargando…
The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease
Parkinson’s disease is a chronic, progressive, and neurodegenerative disease, and yet with an imprecise etiopathogenesis. Although neuroinflammation was initially thought to be a secondary condition, it is now believed that microglia-induced inflammation could also contribute to the degeneration of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778576/ https://www.ncbi.nlm.nih.gov/pubmed/36554101 http://dx.doi.org/10.3390/healthcare10122578 |
_version_ | 1784856396771098624 |
---|---|
author | Stanca, Iulia-Diana Criciotoiu, Oana Neamtu, Simona-Daniela Vasile, Ramona-Constantina Berceanu-Bora, Nicoleta-Madalina Minca, Teodora-Nicoleta Pirici, Ionica Rosu, Gabriela-Camelia Bondari, Simona |
author_facet | Stanca, Iulia-Diana Criciotoiu, Oana Neamtu, Simona-Daniela Vasile, Ramona-Constantina Berceanu-Bora, Nicoleta-Madalina Minca, Teodora-Nicoleta Pirici, Ionica Rosu, Gabriela-Camelia Bondari, Simona |
author_sort | Stanca, Iulia-Diana |
collection | PubMed |
description | Parkinson’s disease is a chronic, progressive, and neurodegenerative disease, and yet with an imprecise etiopathogenesis. Although neuroinflammation was initially thought to be a secondary condition, it is now believed that microglia-induced inflammation could also contribute to the degeneration of the nigrostriatal pathway. Here, we aimed to establish the feasibility of basic inflammatory biomarkers as prognostic factors in PD. The study was based on retrospective analyses of blood samples taken from patients diagnosed with PD, as well as from healthy subjects. Complete medical records, total leukocyte count with subpopulations, and erythrocyte sedimentation rate (ESR) were analyzed. We calculated the serum neutrophils-to-lymphocytes ratio (NLR) and platelet-to lymphocytes ratio (PLR), and also compared the laboratory data between the PD group and the control group. Only PLR and NLR showed statistically significant differences (p < 0.001 and 0.04, respectively). In our study, ESR did not show statistically significant correlations with motor score or with disability. In our research, ESR was correlated with the disease duration (p = 0.04), and PLR showed a significant correlation with disease stage (p = 0.027) and disease duration (p = 0.001), but not with motor state. These biomarkers could prove to be effective tools for a primary evaluation of inflammation in PD, but further tests are required to properly investigate the neuroinflammatory status of these patients. |
format | Online Article Text |
id | pubmed-9778576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97785762022-12-23 The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease Stanca, Iulia-Diana Criciotoiu, Oana Neamtu, Simona-Daniela Vasile, Ramona-Constantina Berceanu-Bora, Nicoleta-Madalina Minca, Teodora-Nicoleta Pirici, Ionica Rosu, Gabriela-Camelia Bondari, Simona Healthcare (Basel) Article Parkinson’s disease is a chronic, progressive, and neurodegenerative disease, and yet with an imprecise etiopathogenesis. Although neuroinflammation was initially thought to be a secondary condition, it is now believed that microglia-induced inflammation could also contribute to the degeneration of the nigrostriatal pathway. Here, we aimed to establish the feasibility of basic inflammatory biomarkers as prognostic factors in PD. The study was based on retrospective analyses of blood samples taken from patients diagnosed with PD, as well as from healthy subjects. Complete medical records, total leukocyte count with subpopulations, and erythrocyte sedimentation rate (ESR) were analyzed. We calculated the serum neutrophils-to-lymphocytes ratio (NLR) and platelet-to lymphocytes ratio (PLR), and also compared the laboratory data between the PD group and the control group. Only PLR and NLR showed statistically significant differences (p < 0.001 and 0.04, respectively). In our study, ESR did not show statistically significant correlations with motor score or with disability. In our research, ESR was correlated with the disease duration (p = 0.04), and PLR showed a significant correlation with disease stage (p = 0.027) and disease duration (p = 0.001), but not with motor state. These biomarkers could prove to be effective tools for a primary evaluation of inflammation in PD, but further tests are required to properly investigate the neuroinflammatory status of these patients. MDPI 2022-12-19 /pmc/articles/PMC9778576/ /pubmed/36554101 http://dx.doi.org/10.3390/healthcare10122578 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Stanca, Iulia-Diana Criciotoiu, Oana Neamtu, Simona-Daniela Vasile, Ramona-Constantina Berceanu-Bora, Nicoleta-Madalina Minca, Teodora-Nicoleta Pirici, Ionica Rosu, Gabriela-Camelia Bondari, Simona The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title | The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title_full | The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title_fullStr | The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title_full_unstemmed | The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title_short | The Analysis of Blood Inflammation Markers as Prognostic Factors in Parkinson’s Disease |
title_sort | analysis of blood inflammation markers as prognostic factors in parkinson’s disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778576/ https://www.ncbi.nlm.nih.gov/pubmed/36554101 http://dx.doi.org/10.3390/healthcare10122578 |
work_keys_str_mv | AT stancaiuliadiana theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT criciotoiuoana theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT neamtusimonadaniela theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT vasileramonaconstantina theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT berceanuboranicoletamadalina theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT mincateodoranicoleta theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT piriciionica theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT rosugabrielacamelia theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT bondarisimona theanalysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT stancaiuliadiana analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT criciotoiuoana analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT neamtusimonadaniela analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT vasileramonaconstantina analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT berceanuboranicoletamadalina analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT mincateodoranicoleta analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT piriciionica analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT rosugabrielacamelia analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease AT bondarisimona analysisofbloodinflammationmarkersasprognosticfactorsinparkinsonsdisease |